Nicotine Research Group - About

Our main focus is on reducing the population harms caused by nicotine and tobacco products. Our research spans clinical trials of new smoking cessation and harm reduction interventions, policy analyses and evaluation, epidemiology and qualitative research. Our research includes strategies aimed at the whole population and also targeted interventions for priority populations, particularly people living with medical conditions (e.g. mental health disorders, substance use disorders, HIV).